MEDINDIA
English
हिन्दी
Español
français
中文
Email
Abciximab
Flurbiprofen may increase the anticoagulant activities of Abciximab.
Abiraterone
The metabolism of Flurbiprofen can be decreased when combined with Abiraterone.
Acebutolol
Flurbiprofen may decrease the antihypertensive activities of Acebutolol.
Aceclofenac
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Aceclofenac.
Acemetacin
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Acemetacin.
Acenocoumarol
Flurbiprofen may increase the anticoagulant activities of Acenocoumarol.
Acetyl salicylate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Acetylsalicylic acid.
Aclarubicin
Flurbiprofen may decrease the excretion rate of Aclarubicin which could result in a higher serum level.
Adapalene
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Adapalene.
Alclometasone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Alclometasone.
Aldosterone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Aldosterone.
Alendronate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Alendronic acid.
Alendronic acid
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Alendronic acid.
Aliskiren
Flurbiprofen may decrease the antihypertensive activities of Aliskiren.
Alminoprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Alminoprofen.
Alprenolol
Flurbiprofen may decrease the antihypertensive activities of Alprenolol.
Alprostadil
The therapeutic efficacy of Alprostadil can be decreased when used in combination with Flurbiprofen.
Amcinonide
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Amcinonide.
Amikacin
Flurbiprofen may decrease the excretion rate of Amikacin which could result in a higher serum level.
Amiloride
Flurbiprofen may decrease the antihypertensive activities of Amiloride.
Amiodarone
The metabolism of Flurbiprofen can be decreased when combined with Amiodarone.
Ancrod
Flurbiprofen may increase the anticoagulant activities of Ancrod.
Androstenedione
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Androstenedione.
Anhydrous Tacrolimus
Flurbiprofen may increase the nephrotoxic activities of Tacrolimus.
Antipyrine
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Antipyrine.
Antithrombin III
Flurbiprofen may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Flurbiprofen may increase the anticoagulant activities of Antithrombin III human.
Apalutamide
The serum concentration of Flurbiprofen can be decreased when it is combined with Apalutamide.
Apazone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Azapropazone.
Apixaban
Flurbiprofen may increase the anticoagulant activities of Apixaban.
Apremilast
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Apremilast.
Aprepitant
The metabolism of Flurbiprofen can be increased when combined with Aprepitant.
Arbekacin
Flurbiprofen may decrease the excretion rate of Arbekacin which could result in a higher serum level.
Ardeparin
Flurbiprofen may increase the anticoagulant activities of Ardeparin.
Argatroban
Flurbiprofen may increase the anticoagulant activities of Argatroban.
Argatroban Anhydrous
Flurbiprofen may increase the anticoagulant activities of Argatroban.
Aspirin
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Acetylsalicylic acid.
Atenolol
Flurbiprofen may decrease the antihypertensive activities of Atenolol.
Azelastine
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Azelastine.
azficel-T
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Azficel-T.
Azilsartan
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Flurbiprofen.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Flurbiprofen.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Flurbiprofen.
Azosemide
The therapeutic efficacy of Azosemide can be decreased when used in combination with Flurbiprofen.
Balsalazide
Flurbiprofen may increase the nephrotoxic activities of Balsalazide.
Becaplermin
Flurbiprofen may increase the anticoagulant activities of Becaplermin.
Beclomethasone Dipropionate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Beclomethasone dipropionate.
Benazepril
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Benazepril.
Bendroflumethiazide
The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Flurbiprofen.
Benzydamine
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Benzydamine.
Betamethasone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Betamethasone.
Betaxolol
Flurbiprofen may decrease the antihypertensive activities of Betaxolol.
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Flurbiprofen.
Bimatoprost
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Flurbiprofen.
Bisoprolol
Flurbiprofen may decrease the antihypertensive activities of Bisoprolol.
Bivalirudin
Flurbiprofen may increase the anticoagulant activities of Bivalirudin.
Bopindolol
Flurbiprofen may decrease the antihypertensive activities of Bopindolol.
Bromfenac
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Bromfenac.
Budesonide
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Budesonide.
Bufexamac
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Bufexamac.
Bumetanide
The therapeutic efficacy of Bumetanide can be decreased when used in combination with Flurbiprofen.
Bupranolol
Flurbiprofen may decrease the antihypertensive activities of Bupranolol.
Candesartan
The risk or severity of adverse effects can be increased when Candesartan is combined with Flurbiprofen.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Flurbiprofen.
Capecitabine
The metabolism of Flurbiprofen can be decreased when combined with Capecitabine.
Captopril
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Captopril.
Carbamazepine
The metabolism of Flurbiprofen can be increased when combined with Carbamazepine.
Carboprost
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Flurbiprofen.
Carboprost Tromethamine
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Flurbiprofen.
Carprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Carprofen.
Carteolol
Flurbiprofen may decrease the antihypertensive activities of Carteolol.
Carvedilol
Flurbiprofen may decrease the antihypertensive activities of Carvedilol.
Celecoxib
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Celecoxib.
Celiprolol
Flurbiprofen may decrease the antihypertensive activities of Celiprolol.
Ceritinib
The serum concentration of Flurbiprofen can be increased when it is combined with Ceritinib.
Certoparin
Flurbiprofen may increase the anticoagulant activities of Certoparin.
Chloroquine
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Chloroquine.
Chlorothiazide
The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Flurbiprofen.
Chlorthalidone
The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Flurbiprofen.
Cholecalciferol
The metabolism of Flurbiprofen can be decreased when combined with Cholecalciferol.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Flurbiprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Choline magnesium trisalicylate.
Ciclesonide
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Ciclesonide.
Cilazapril
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Cilazapril.
Cinoxacin
Flurbiprofen may increase the neuroexcitatory activities of Cinoxacin.
Citric Acid
Flurbiprofen may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Flurbiprofen may increase the anticoagulant activities of Citric Acid.
Clobetasol
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Clobetasol.
Clobetasol Propionate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Clobetasol propionate.
Clobetasone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Clobetasone.
Clocortolone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Clocortolone.
Clodronic Acid
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Clodronic Acid.
Clonixin
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Clonixin.
Clotrimazole
The metabolism of Flurbiprofen can be decreased when combined with Clotrimazole.
Colesevelam
Colesevelam can cause a decrease in the absorption of Flurbiprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Flurbiprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cortisone Acetate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Cortisone acetate.
Crisaborole
The metabolism of Flurbiprofen can be decreased when combined with Crisaborole.
Curcumin
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Curcumin.
Cyclopenthiazide
The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Flurbiprofen.
Cyclosporine
Flurbiprofen may increase the nephrotoxic activities of Cyclosporine.
Dabigatran Etexilate
Flurbiprofen may increase the anticoagulant activities of Dabigatran etexilate.
Dabrafenib
The serum concentration of Flurbiprofen can be decreased when it is combined with Dabrafenib.
Dalteparin
Flurbiprofen may increase the anticoagulant activities of Dalteparin.
Danaparoid
Flurbiprofen may increase the anticoagulant activities of Danaparoid.
Daunorubicin
Flurbiprofen may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Deferasirox
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Deferasirox.
Deflazacort
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Deflazacort.
Delavirdine
The metabolism of Flurbiprofen can be decreased when combined with Delavirdine.
Desirudin
Flurbiprofen may increase the anticoagulant activities of Desirudin.
Desmopressin
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Desmopressin.
Desonide
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Desonide.
Desoximetasone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Desoximetasone.
Desoxycorticosterone acetate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Desoxycorticosterone acetate.
Desoxycorticosterone Pivalate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Desoxycorticosterone Pivalate.
Dexamethasone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Dexamethasone.
Dexketoprofen
The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Flurbiprofen.
Dextran
Flurbiprofen may increase the anticoagulant activities of Dextran.
Dextran 40
Flurbiprofen may increase the anticoagulant activities of Dextran 40.
Dextran 70
Flurbiprofen may increase the anticoagulant activities of Dextran 70.
Dextran 75
Flurbiprofen may increase the anticoagulant activities of Dextran 75.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Flurbiprofen.
Dicumarol
Flurbiprofen may increase the anticoagulant activities of Dicoumarol.
Diflorasone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Diflorasone.
Diflucortolone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Difluocortolone.
Diflunisal
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Diflunisal.
Difluprednate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Difluprednate.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Flurbiprofen.
Dihydrostreptomycin
Flurbiprofen may decrease the excretion rate of Dihydrostreptomycin which could result in a higher serum level.
Dinoprost
The therapeutic efficacy of Dinoprost can be decreased when used in combination with Flurbiprofen.
Dinoprost Tromethamine
The therapeutic efficacy of Dinoprost Tromethamine can be decreased when used in combination with Flurbiprofen.
Dinoprostone
The therapeutic efficacy of Dinoprostone can be decreased when used in combination with Flurbiprofen.
Dipyrone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Metamizole.
Dothiepin
The metabolism of Flurbiprofen can be decreased when combined with Dosulepin.
Doxorubicin
Flurbiprofen may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Doxorubicin Hydrochloride
Flurbiprofen may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Drospirenone
Flurbiprofen may increase the hyperkalemic activities of Drospirenone.
Droxicam
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Droxicam.
Edetic Acid
Flurbiprofen may increase the anticoagulant activities of Edetic Acid.
Edoxaban
Flurbiprofen may increase the anticoagulant activities of Edoxaban.
Efavirenz
The metabolism of Flurbiprofen can be decreased when combined with Efavirenz.
Enalapril
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Enalapril.
Enalaprilat
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Enalaprilat.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Enalaprilat.
Enoxacin
Flurbiprofen may increase the neuroexcitatory activities of Enoxacin.
Enoxaparin
Flurbiprofen may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Flurbiprofen may increase the anticoagulant activities of Enoxaparin.
Epirubicin
Flurbiprofen may decrease the excretion rate of Epirubicin which could result in a higher serum level.
Eplerenone
Flurbiprofen may decrease the antihypertensive activities of Eplerenone.
Epoprostenol
The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Flurbiprofen.
Eprosartan
The risk or severity of adverse effects can be increased when Eprosartan is combined with Flurbiprofen.
Esmolol
Flurbiprofen may decrease the antihypertensive activities of Esmolol.
Estrone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Estrone.
Etanercept
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Etanercept.
Ethacrynate
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Flurbiprofen.
Ethacrynic Acid
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Flurbiprofen.
Ethylenediaminetetraacetate
Flurbiprofen may increase the anticoagulant activities of Edetic Acid.
Etidronate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Etidronic acid.
Etidronic Acid
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Etidronic acid.
Etodolac
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Etodolac.
Etofenamate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Etofenamate.
Etoricoxib
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Etoricoxib.
Etravirine
The metabolism of Flurbiprofen can be decreased when combined with Etravirine.
Evening primrose oil
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Evening primrose oil.
Felbinac
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Felbinac.
Fenbufen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Fenbufen.
Fenoprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Fenoprofen.
Ferulic Acid
Flurbiprofen may increase the anticoagulant activities of Ferulic acid.
Fleroxacin
Flurbiprofen may increase the neuroexcitatory activities of Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Flurbiprofen.
Floxuridine
The metabolism of Flurbiprofen can be decreased when combined with Floxuridine.
Fluconazole
The metabolism of Flurbiprofen can be decreased when combined with Fluconazole.
Fludrocortisone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Fludrocortisone.
Fluindione
Flurbiprofen may increase the anticoagulant activities of Fluindione.
Flumequine
Flurbiprofen may increase the neuroexcitatory activities of Flumequine.
Flumethasone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Flumethasone.
Flunisolide
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Flunisolide.
Flunisolide Anhydrous (obsolete)
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Flunisolide.
Fluocinolone Acetonide
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Fluocinolone Acetonide.
Fluocinonide
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Fluocinonide.
Fluocortolone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Fluocortolone.
Fluorometholone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Fluorometholone.
Fluorouracil
The metabolism of Flurbiprofen can be decreased when combined with Fluorouracil.
FLUPREDNIDENE
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Fluprednidene.
Fluprednisolone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Fluprednisolone.
Flurandrenolide
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Flurandrenolide.
Fluticasone Furoate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Fluticasone furoate.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Fluticasone propionate.
Fluvastatin
The metabolism of Flurbiprofen can be decreased when combined with Fluvastatin.
Fluvoxamine
The metabolism of Flurbiprofen can be decreased when combined with Fluvoxamine.
Folate
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Flurbiprofen.
Folic Acid
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Flurbiprofen.
Fondaparinux
Flurbiprofen may increase the anticoagulant activities of Fondaparinux.
Fondaparinux sodium
Flurbiprofen may increase the anticoagulant activities of Fondaparinux sodium.
Formestane
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Formestane.
Fosinopril
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Fosinopril.
Fosphenytoin
The metabolism of Flurbiprofen can be increased when combined with Fosphenytoin.
Framycetin
Flurbiprofen may decrease the excretion rate of Framycetin which could result in a higher serum level.
Furosemide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Flurbiprofen.
Gatifloxacin
Flurbiprofen may increase the neuroexcitatory activities of Gatifloxacin.
Gatifloxacin Anhydrous
Flurbiprofen may increase the neuroexcitatory activities of Gatifloxacin.
Gemeprost
The therapeutic efficacy of Gemeprost can be decreased when used in combination with Flurbiprofen.
Gemfibrozil
The metabolism of Flurbiprofen can be decreased when combined with Gemfibrozil.
Gemifloxacin
Flurbiprofen may increase the neuroexcitatory activities of Gemifloxacin.
Gemifloxacin Mesylate
Flurbiprofen may increase the neuroexcitatory activities of Gemifloxacin.
Gentamicin
Flurbiprofen may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Grepafloxacin
Flurbiprofen may increase the neuroexcitatory activities of Grepafloxacin.
Halcinonide
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Halcinonide.
Halobetasol
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Ulobetasol.
Haloperidol
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Haloperidol.
Heparin
Flurbiprofen may increase the anticoagulant activities of Heparin.
Hydralazine
Flurbiprofen may decrease the antihypertensive activities of Hydralazine.
Hydrochlorothiazide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Flurbiprofen.
Hydrocortisone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Flurbiprofen.
Ibandronate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Ibandronate.
Ibandronic Acid
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Ibandronate.
Ibuprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Ibuprofen.
Icatibant
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Icatibant.
Idarubicin
Flurbiprofen may decrease the excretion rate of Idarubicin which could result in a higher serum level.
Iloprost
The therapeutic efficacy of Iloprost can be decreased when used in combination with Flurbiprofen.
Imidapril
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Imidapril.
Indapamide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Flurbiprofen.
Indinavir
The metabolism of Flurbiprofen can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Flurbiprofen can be decreased when combined with Indinavir.
Indobufen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Indobufen.
Indomethacin
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Indomethacin.
Irbesartan
The metabolism of Flurbiprofen can be decreased when combined with Irbesartan.
Kanamycin
Flurbiprofen may decrease the excretion rate of Kanamycin which could result in a higher serum level.
kanamycin A
Flurbiprofen may decrease the excretion rate of Kanamycin which could result in a higher serum level.
Kebuzone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Kebuzone.
Ketoconazole
The metabolism of Flurbiprofen can be decreased when combined with Ketoconazole.
Ketoprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Ketoprofen.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Flurbiprofen.
Labetalol
Flurbiprofen may decrease the antihypertensive activities of Labetalol.
Latanoprost
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Flurbiprofen.
Latanoprostene Bunod
The therapeutic efficacy of Latanoprostene Bunod can be decreased when used in combination with Flurbiprofen.
Leflunomide
The metabolism of Flurbiprofen can be decreased when combined with Leflunomide.
Lepirudin
Flurbiprofen may increase the anticoagulant activities of Lepirudin.
Levobunolol
Flurbiprofen may decrease the antihypertensive activities of Levobunolol.
Levofloxacin
Flurbiprofen may increase the neuroexcitatory activities of Levofloxacin.
Levofloxacin Anhydrous
Flurbiprofen may increase the neuroexcitatory activities of Levofloxacin.
Limonene, (+)-
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with (4R)-limonene.
Lisinopril
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Lisinopril.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Lisinopril.
Lithium
The serum concentration of Lithium can be increased when it is combined with Flurbiprofen.
Lithium Cation
The serum concentration of Lithium can be increased when it is combined with Flurbiprofen.
Lornoxicam
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Lornoxicam.
Losartan
The metabolism of Flurbiprofen can be decreased when combined with Losartan.
Loteprednol
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Loteprednol.
Lovastatin
The metabolism of Flurbiprofen can be decreased when combined with Lovastatin.
Loxoprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Loxoprofen.
Lubiprostone
The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Flurbiprofen.
Lumacaftor
The serum concentration of Flurbiprofen can be decreased when it is combined with Lumacaftor.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Magnesium salicylate.
Manidipine
The metabolism of Flurbiprofen can be decreased when combined with Manidipine.
Masoprocol
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Masoprocol.
Meclofenamate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Meclofenamic acid.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Meclofenamic acid.
Medronate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Technetium Tc-99m medronate.
Medrysone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Medrysone.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Mefenamic acid.
Meloxicam
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Meloxicam.
Mesalamine
Flurbiprofen may increase the nephrotoxic activities of Mesalazine.
Methotrexate
The serum concentration of Methotrexate can be increased when it is combined with Flurbiprofen.
Methyclothiazide
The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Flurbiprofen.
Methylprednisolone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Methylprednisolone.
Metipranolol
Flurbiprofen may decrease the antihypertensive activities of Metipranolol.
Metolazone
The therapeutic efficacy of Metolazone can be decreased when used in combination with Flurbiprofen.
Metoprolol
Flurbiprofen may decrease the antihypertensive activities of Metoprolol.
Metrizamide
Flurbiprofen may decrease the excretion rate of Metrizamide which could result in a higher serum level.
Midostaurin
The metabolism of Flurbiprofen can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Flurbiprofen can be increased when it is combined with Mifepristone.
Misoprostol
The therapeutic efficacy of Misoprostol can be decreased when used in combination with Flurbiprofen.
Moexipril
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Moexipril.
Mometasone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Mometasone.
Morniflumate
The risk or severity of adverse effects can be increased when Morniflumate is combined with Flurbiprofen.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Mycophenolic acid.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Mycophenolate mofetil.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Mycophenolic acid.
Nabumetone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Nabumetone.
Nadolol
Flurbiprofen may decrease the antihypertensive activities of Nadolol.
Nadroparin
Flurbiprofen may increase the anticoagulant activities of Nadroparin.
Naftifine
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Naftifine.
Nalidixic Acid
Flurbiprofen may increase the neuroexcitatory activities of Nalidixic Acid.
Naproxen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Naproxen.
Nebivolol
Flurbiprofen may decrease the antihypertensive activities of Nebivolol.
Neomycin
Flurbiprofen may decrease the excretion rate of Neomycin which could result in a higher serum level.
Nepafenac
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Nepafenac.
Netilmicin
Flurbiprofen may decrease the excretion rate of Netilmicin which could result in a higher serum level.
Nicardipine
The metabolism of Flurbiprofen can be decreased when combined with Nicardipine.
Niflumic Acid
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Niflumic Acid.
Nimesulide
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Nimesulide.
Norfloxacin
Flurbiprofen may increase the neuroexcitatory activities of Norfloxacin.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Evening primrose oil.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Flurbiprofen.
Olopatadine
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Olopatadine.
Olsalazine
Flurbiprofen may increase the nephrotoxic activities of Olsalazine.
Omacetaxine Mepesuccinate
The risk or severity of bleeding can be increased when Flurbiprofen is combined with Omacetaxine mepesuccinate.
Omeprazole
The metabolism of Flurbiprofen can be decreased when combined with Omeprazole.
Oxaprozin
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Oxaprozin.
Oxprenolol
Flurbiprofen may decrease the antihypertensive activities of Oxprenolol.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Oxyphenbutazone.
Pamidronate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Pamidronate.
Pamidronic Acid
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Pamidronate.
Paramethasone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Paramethasone.
Parecoxib
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Parecoxib.
Paromomycin
Flurbiprofen may decrease the excretion rate of Paromomycin which could result in a higher serum level.
Parthenolide
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Parthenolide.
Pefloxacin
Flurbiprofen may increase the neuroexcitatory activities of Pefloxacin.
Penbutolol
Flurbiprofen may decrease the antihypertensive activities of Penbutolol.
Pentaerythritol Tetranitrate
Flurbiprofen may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentosan Polysulfate
Flurbiprofen may increase the anticoagulant activities of Pentosan Polysulfate.
Perindopril
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Perindopril.
Phenindione
Flurbiprofen may increase the anticoagulant activities of Phenindione.
Phenobarbital
The metabolism of Flurbiprofen can be increased when combined with Phenobarbital.
Phenprocoumon
Flurbiprofen may increase the anticoagulant activities of Phenprocoumon.
Phenylbutazone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Phenylbutazone.
Phenytoin
The metabolism of Flurbiprofen can be increased when combined with Phenytoin.
Pimecrolimus
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Pimecrolimus.
Pindolol
Flurbiprofen may decrease the antihypertensive activities of Pindolol.
Pirarubicin
Flurbiprofen may decrease the excretion rate of Pirarubicin which could result in a higher serum level.
Piretanide
The therapeutic efficacy of Piretanide can be decreased when used in combination with Flurbiprofen.
Pirfenidone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Pirfenidone.
Piroxicam
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Piroxicam.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Piroxicam.
Plicamycin
Flurbiprofen may decrease the excretion rate of Plicamycin which could result in a higher serum level.
Polythiazide
The therapeutic efficacy of Polythiazide can be decreased when used in combination with Flurbiprofen.
Practolol
Flurbiprofen may decrease the antihypertensive activities of Practolol.
Pralatrexate
The serum concentration of Pralatrexate can be increased when it is combined with Flurbiprofen.
Prasterone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Prasterone.
Prednicarbate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Prednicarbate.
Prednisolone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Prednisolone.
Prednisone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Prednisone.
Pregnenolone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Pregnenolone.
Primidone
The metabolism of Flurbiprofen can be increased when combined with Primidone.
Probenecid
The serum concentration of Flurbiprofen can be increased when it is combined with Probenecid.
Propranolol
Flurbiprofen may decrease the antihypertensive activities of Propranolol.
protein C, human
Flurbiprofen may increase the anticoagulant activities of Protein C.
protein S, human
Flurbiprofen may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Flurbiprofen may increase the anticoagulant activities of Protocatechualdehyde.
Pyrimethamine
The metabolism of Flurbiprofen can be decreased when combined with Pyrimethamine.
Quinapril
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Quinapril.
Quinethazone
The therapeutic efficacy of Quinethazone can be decreased when used in combination with Flurbiprofen.
Quinine
The metabolism of Flurbiprofen can be decreased when combined with Quinine.
Ramipril
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Ramipril.
Rescinnamine
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Rescinnamine.
Resveratrol
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Resveratrol.
Reviparin
Flurbiprofen may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Flurbiprofen may increase the anticoagulant activities of Reviparin.
Rifampin
The metabolism of Flurbiprofen can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Flurbiprofen can be increased when combined with Rifapentine.
Rimexolone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Rimexolone.
Risedronate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Risedronate.
Risedronic Acid
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Risedronate.
Rivaroxaban
Flurbiprofen may increase the anticoagulant activities of Rivaroxaban.
Rofecoxib
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Rofecoxib.
Rosoxacin
Flurbiprofen may increase the neuroexcitatory activities of Rosoxacin.
Rucaparib
The metabolism of Flurbiprofen can be decreased when combined with Rucaparib.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Flurbiprofen.
Salicylamide
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Salicylamide.
Salicylic Acid
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Salicylic acid.
Salsalate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Salsalate.
Saralasin
The risk or severity of adverse effects can be increased when Saralasin is combined with Flurbiprofen.
Sarilumab
Sarilumab may increase the immunosuppressive activities of Flurbiprofen.
Secobarbital
The metabolism of Flurbiprofen can be increased when combined with Secobarbital.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Serrapeptase.
Sildenafil
The metabolism of Flurbiprofen can be decreased when combined with Sildenafil.
Sisomicin
Flurbiprofen may decrease the excretion rate of Sisomicin which could result in a higher serum level.
Sodium Phosphate
Sodium phosphate may increase the nephrotoxic activities of Flurbiprofen.
Sodium Phosphate, Monobasic
Sodium phosphate may increase the nephrotoxic activities of Flurbiprofen.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Sodium phosphate may increase the nephrotoxic activities of Flurbiprofen.
Sorafenib
The metabolism of Flurbiprofen can be decreased when combined with Sorafenib.
Sotalol
Flurbiprofen may decrease the antihypertensive activities of Sotalol.
Sparfloxacin
Flurbiprofen may increase the neuroexcitatory activities of Sparfloxacin.
Spectinomycin
Flurbiprofen may decrease the excretion rate of Spectinomycin which could result in a higher serum level.
Spirapril
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Spirapril.
Spironolactone
Flurbiprofen may decrease the antihypertensive activities of Spironolactone.
Streptomycin
Flurbiprofen may decrease the excretion rate of Streptomycin which could result in a higher serum level.
Streptozocin
Flurbiprofen may decrease the excretion rate of Streptozocin which could result in a higher serum level.
Sulfadiazine
The metabolism of Flurbiprofen can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Flurbiprofen can be decreased when combined with Sulfamethoxazole.
Sulfasalazine
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Sulfasalazine.
Sulfisoxazole
The metabolism of Flurbiprofen can be decreased when combined with Sulfisoxazole.
Sulindac
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Sulindac.
Suprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Suprofen.
Tacrolimus
Flurbiprofen may increase the nephrotoxic activities of Tacrolimus.
Tafluprost
The therapeutic efficacy of Tafluprost can be decreased when used in combination with Flurbiprofen.
Talinolol
Flurbiprofen may decrease the antihypertensive activities of Talinolol.
Talniflumate
The risk or severity of adverse effects can be increased when Talniflumate is combined with Flurbiprofen.
Technetium Tc 99m Medronate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Technetium Tc-99m medronate.
Telmisartan
The risk or severity of adverse effects can be increased when Telmisartan is combined with Flurbiprofen.
Temafloxacin
Flurbiprofen may increase the neuroexcitatory activities of Temafloxacin.
Tenofovir Disoproxil
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Tenofovir disoproxil.
Tenoxicam
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Tenoxicam.
Teriflunomide
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Teriflunomide.
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Tiaprofenic acid.
Ticagrelor
The metabolism of Flurbiprofen can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Flurbiprofen can be decreased when combined with Ticlopidine.
Tiludronate
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Tiludronic acid.
Tiludronic Acid
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Tiludronic acid.
Timolol
Flurbiprofen may decrease the antihypertensive activities of Timolol.
Timolol Anhydrous
Flurbiprofen may decrease the antihypertensive activities of Timolol.
Tixocortol
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Tixocortol.
Tobramycin
Flurbiprofen may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Tolbutamide
The metabolism of Flurbiprofen can be decreased when combined with Tolbutamide.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Tolfenamic Acid.
Tolmetin
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Tolmetin.
Torsemide
The therapeutic efficacy of Torasemide can be decreased when used in combination with Flurbiprofen.
Trandolapril
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Trandolapril.
Tranilast
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Tranilast.
Travoprost
The therapeutic efficacy of Travoprost can be decreased when used in combination with Flurbiprofen.
Treprostinil
The risk or severity of adverse effects can be increased when Treprostinil is combined with Flurbiprofen.
Triamcinolone
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Triamcinolone.
Triamterene
Flurbiprofen may decrease the antihypertensive activities of Triamterene.
Trichlormethiazide
The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Flurbiprofen.
Trimethoprim
The metabolism of Flurbiprofen can be decreased when combined with Trimethoprim.
Trovafloxacin
Flurbiprofen may increase the neuroexcitatory activities of Trovafloxacin.
Troxerutin
Flurbiprofen may increase the anticoagulant activities of Troxerutin.
UNOPROSTONE
The therapeutic efficacy of Unoprostone can be decreased when used in combination with Flurbiprofen.
Valdecoxib
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Valdecoxib.
Valproate
The metabolism of Flurbiprofen can be decreased when combined with Valproic Acid.
Valproic Acid
The metabolism of Flurbiprofen can be decreased when combined with Valproic Acid.
Valrubicin
Flurbiprofen may decrease the excretion rate of Valrubicin which could result in a higher serum level.
Valsartan
The metabolism of Flurbiprofen can be decreased when combined with Valsartan.
Vancomycin
The serum concentration of Vancomycin can be increased when it is combined with Flurbiprofen.
Voriconazole
The metabolism of Flurbiprofen can be decreased when combined with Voriconazole.
Warfarin
Flurbiprofen may increase the anticoagulant activities of Warfarin.
Zafirlukast
The metabolism of Flurbiprofen can be decreased when combined with Zafirlukast.
Zileuton
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Zileuton.
Zofenopril
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Zofenopril.
Zoledronic Acid
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Zoledronic acid.
Zoledronic Acid Anhydrous
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Zoledronic acid.
Zomepirac
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Zomepirac.
